首頁 > 市場調查報告書 > 製藥

基因治療學和RNAi

勝任細胞市場規模、佔有率及成長分析（按類型、應用、最終用戶和地區分類）－2026-2033年產業預測

市場調查報告書

商品編碼

1899434

勝任細胞市場規模、佔有率及成長分析（按類型、應用、最終用戶和地區分類）－2026-2033年產業預測

Competent Cells Market Size, Share, and Growth Analysis, By Type (Chemically Competent Cells, Electrocompetent Cells), By Application (Cloning, Subcloning & Routine Cloning), By End User, By Region - Industry Forecast 2026-2033

出版日期: 2025年12月17日 | 出版商:

SkyQuest | 英文 157 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

預計到 2024 年，全球勝任細胞市場規模將達到 23 億美元，到 2025 年將達到 24.9 億美元，到 2033 年將達到 46.4 億美元，預測期（2026-2033 年）的複合年成長率為 8.1%。

受公共和私人領域對分子克隆研究投資不斷增加的推動，全球勝任細胞市場正經歷顯著成長。大腸桿菌勝任細胞以能夠整合染色體外DNA而聞名，可透過氯化鈣處理和熱休克等技術高效整合。這項特異性特性正推動著消費者對分子克隆產品的持續需求。此外，各項政府措施以及醫療保健支出的成長也對市場擴張產生了正面影響。人們對創新細胞技術的整體認知不斷提高，加劇了生物技術領域的競爭格局。這些因素預計將推動全球勝任細胞市場取得重大發展，以滿足全球科學研究和醫療保健產業不斷變化的需求。

全球勝任細胞市場促進因素

全球勝任細胞市場預計將持續成長，這主要得益於重組DNA技術產品開發需求的不斷成長以及分子工程技術的進步。針對多種疾病的治療藥物研發活動的激增，預計將進一步推動市場擴張。有利的健保報銷和法規環境也將對市場產生正面影響。此外，企業對分子克隆產品和重組蛋白日益成長的商業性興趣，以及政府對舉措研究的投入不斷增加，預計將顯著推動市場發展，並在不久的將來為該行業帶來強勁的成長勢頭。

全球勝任細胞市場限制因素

全球勝任細胞市場面臨許多限制因素，可能阻礙其成長。其中一個主要障礙是勝任細胞試劑盒的高成本，這可能會限制部分使用者群體的取得。此外，市場整合程度的提高也提高了進入門檻，使得新進業者難以進入市場。同時，該領域經驗豐富的專業人員匱乏也是一個挑戰，這可能會阻礙勝任細胞在研究和應用中的創新和有效利用。這些因素共同構成了一個抑制市場擴張的環境。

全球勝任細胞市場趨勢

受分子克隆產品需求成長和克隆研究進展的推動，全球勝任細胞市場預計將迎來顯著成長。來自各機構的資金支持也進一步促進了市場擴張，而諸如體細胞核移植（SCNT）等創新細胞工程技術的出現，則開闢了包括基因改造動物開發和治療性克隆在內的多元化應用領域。人們對保護瀕危物種和加強生物製藥研究的日益關注，並有望重新激發對勝任細胞在這些領域效用的興趣，最終推動生物技術和醫療領域對勝任細胞的強勁需求。

北美洲
- 美國
- 加拿大
歐洲
- 德國
- 西班牙
- 法國
- 英國
- 義大利
- 其他歐洲地區
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 亞太其他地區
拉丁美洲
- 巴西
- 其他拉丁美洲地區
中東和非洲
- 海灣合作理事會國家
- 南非
- 其他中東和非洲地區

競爭資訊

前五大公司對比
主要企業的市場定位（2025 年）
主要市場參與者所採取的策略
近期市場趨勢
公司市佔率分析（2025 年）
主要企業公司簡介
- 公司詳情
- 產品系列分析
- 依業務板塊進行公司股票分析
- 2023-2025年營收年比比較

主要企業簡介

Merck KGaA（Germany）
Promega Corporation（US）
Thermo Fisher Scientific, Inc.（US）
New England Biolabs（US）
Takara Bio（Japan）
Agilent Technologies（US）
Lucigen（Epicenter）（Illumina）（US）
QIAGEN NV（Germany）
OriGene Technologies（US）
Bioline（UK）
Zymo Research（US）
Beijing TransGen Biotech Co., Ltd.（China）
Source BioScience（UK）
IBA GmbH（Germany）
Genewiz（US）
BioDynamics Laboratory, Inc.（Japan）
GCC Biotech（India）
SMOBIO Technology（Taiwan）
GeneScript Corporation（US）
Bio-Rad Laboratories（US）

結論與建議

簡介目錄

Product Code: SQSG35H2024

Global Competent Cells Market size was valued at USD 2.3 Billion in 2024 and is poised to grow from USD 2.49 Billion in 2025 to USD 4.64 Billion by 2033, growing at a CAGR of 8.1% during the forecast period (2026-2033).

The global competent cells market is experiencing significant growth, driven by increased investments from both public and private sectors in molecular cloning research. E. coli competent cells, known for their ability to take up extrachromosomal DNA, utilize methods like calcium chloride treatment and heat shock to enhance DNA integration. This unique characteristic promotes a steady demand for molecularly cloned products among consumers. Furthermore, various government initiatives, coupled with rising healthcare expenditures, contribute positively to market expansion. The overall awareness of innovative cellular techniques continues to grow, reinforcing the competitive landscape within the biotechnology sector. These factors collectively position the global competent cells market for substantial advancement, catering to the evolving needs of research and healthcare industries worldwide.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Competent Cells market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Competent Cells Market Segments Analysis

Global Competent Cells Market is segmented by Type, Application, End User and region. Based on Type, the market is segmented into Chemically Competent Cells and Electrocompetent Cells. Based on Application, the market is segmented into Cloning, Subcloning & Routine Cloning, Phage Display Library Construction, Toxic/Unstable DNA Cloning, High-throughput Cloning, Protein Expression, Other Applications, Mutagenesis, Single-stranded DNA Production, Lentiviral Vector Production and Large Plasmid Transformation. Based on End User, the market is segmented into Pharmaceutical and Biotechnology Companies, Academic Research Institutes and Contract Research Organizations (CROs). Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Competent Cells Market

The Global Competent Cells market is poised for growth, fueled by the increasing demand for products developed through recombinant DNA technology and advancements in molecular engineering. A surge in research and development efforts focused on therapeutic products for various diseases is expected to further drive market expansion. Favorable reimbursement and regulatory environments will also contribute positively to this landscape. Furthermore, rising commercial interest in molecularly cloned products and recombinant proteins, coupled with heightened government investment in research initiatives, will significantly propel the market forward, reflecting a robust trajectory for the industry in the foreseeable future.

Restraints in the Global Competent Cells Market

The Global Competent Cells market faces several constraints that could hinder its growth. One significant obstacle is the high cost associated with competent cell kits, which can limit accessibility for various users. Additionally, the increasing consolidation within the market is raising entry barriers, making it challenging for new players to emerge. Furthermore, a shortage of experienced professionals in the field poses another challenge, as it may impede innovation and the effective use of competent cells in research and applications. Collectively, these factors contribute to a restrained environment for the expansion of the market.

Market Trends of the Global Competent Cells Market

The Global Competent Cells market is poised for significant growth, driven by the rising demand for molecularly cloned products and advancements in cloning research. Financial support from various organizations is further propelling market expansion, as innovative cell engineering techniques-like somatic cell nuclear transfer (SCNT)-unlock diverse applications, including the development of transgenic animals and therapeutic cloning. With the increasing focus on preserving endangered species and enhancing biopharmaceutical research, the utility of competent cells in these areas is set to see renewed interest, ultimately leading to a robust demand for competent cells in the biotechnological and medical sectors.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2025
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Technology Analysis
Regulatory Analysis
Patent Analysis
Case Studies

Global Competent Cells Market Size by Type & CAGR (2026-2033)

Market Overview
Chemically Competent Cells
Electrocompetent Cells

Global Competent Cells Market Size by Application & CAGR (2026-2033)

Market Overview
Cloning
Subcloning & Routine Cloning
Phage Display Library Construction
Toxic/Unstable DNA Cloning
High-throughput Cloning
Protein Expression
Other Applications
Mutagenesis
Single-stranded DNA Production
Lentiviral Vector Production
Large Plasmid Transformation

Global Competent Cells Market Size by End User & CAGR (2026-2033)

Market Overview
Pharmaceutical and Biotechnology Companies
Academic Research Institutes
Contract Research Organizations (CROs)

Global Competent Cells Market Size & CAGR (2026-2033)

North America (Type, Application, End User)
- US
- Canada
Europe (Type, Application, End User)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Type, Application, End User)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Type, Application, End User)
- Brazil
- Rest of Latin America
Middle East & Africa (Type, Application, End User)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2025
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2025
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

Merck KGaA (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Promega Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Thermo Fisher Scientific, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
New England Biolabs (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Takara Bio (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Agilent Technologies (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Lucigen (Epicenter) (Illumina) (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
QIAGEN N.V. (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
OriGene Technologies (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bioline (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Zymo Research (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Beijing TransGen Biotech Co., Ltd. (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Source BioScience (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
IBA GmbH (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Genewiz (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
BioDynamics Laboratory, Inc. (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
GCC Biotech (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
SMOBIO Technology (Taiwan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
GeneScript Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bio-Rad Laboratories (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments